pharma news today obesity drugs glp-1 october 2025 Real-world studies of discontinuation showed that patients often regain weight at a significantly faster pace than after other weight-loss methods. At the same time, however, novel strategies aimed at countering those Novo abruptly ends obesity drug

Yams and Jicama : Dr

Patients not on treatment or on other antihyperglycemic agents entered a run-in treatment period of up to 12 weeks duration with metformin monotherapy (dose of greater than or equal to 1500 mg per day) which included washout of medications other than metformin, if applicable

mellifera workers during topical application experiments (Modafferi et al., 2025)

Nguyn liu Setria t Nht Bn c sn xut bng cng ngh ln men enzyme t nhin theo tiu chun GMP nghim ngt

Herein, we report a GSH-loaded dissolving microneedle (MN) patch prepared with hyaluronic acid (HA) that enables enhanced permeation across the skin and reduces the foul odor of GSH

By activating telomerase and stimulating telomere elongation, Epithalon intervenes at the most fundamental level of cellular aging